Variable

CMC (n = 101)

OMC (n = 28)

PMC (n = 54)

P

Age (years)

43.5 ± 9 7

38.7 ± 10 4

431 ± 9.8

0.071

Sex F/M

73/28

16/12

44/10

0.063

BMI kg/m²

24.2 ± 3.9

23.3 ± 3

23.9 ± 3

0.48

NYHA class III - IV

59 (58.4%)

18 (64.3%)

34 (63%)

0.78

CTI

0.57 ± 0.06

0.58 ± 0.08

0.56 ± 0.05

0.31

AF n (%)

73 (72.3%)

16 (57%)

33 (61%)

0.19

Preop CVA n (%)

2 (2%)

3 (10.7%)

3 (5.6%)

0.11

Renal dysfunction

3 (3%)

0 (0%)

2 (3.7%)

0.6

CPOD (%)

6 (5.9%)

1 (3.6%)

1 (1.9%)

0.48

LA diameter mm

53.9 ± 8,3

58 ± 12.5

52 ± 9.2

0.032

LV ESD mm

33.9 ± 6

34.5 ± 7.5

34.4 ± 7.5

0.89

LV EDD mm

50.5 ± 7.2

53.2 ± 7.6

50.7 ± 8.8

0.3

RF (%)

32 ± 6.9

32.7 ± 6.8

31.9 ± 7.8

0.89

LV EF (%)

60.8 ± 9.4

61.5 ± 9.1

60 ± 9

0.77

SPAP mmhg

50.8 ± 20.5

53.4 ± 20.8

51.6 ± 15.7

0.83

MVA (cm²)

1.05 ± 0.3

1.26 ± 0.4

1.05 ± 0.2

<0.01

Mitral valve gradient (mmhg)

10.8 ± 4.3

9.3 ± 2.6

12.2 ± 4

0.2

Time years Follow-up period

16.8 ± 7.8

11.4 ± 4

7 ± 4

<0.01

LV EF <40%

3 (3%)

1 (3.6%)

2 (3.7%)

0.96

Euroscore

4.84 ± 2

4.96 ± 2

1.73 ± 2.2

<0.01